Hepatitis B Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been receiving antiviral treatment for hepatitis B (a type of medication called nucleoside/nucleotide analogs).
- People whose antiviral treatment has been ongoing for at least 2 years.
- People who had a specific hepatitis B protein (HBeAg) detected in their blood and whose hepatitis B virus levels have remained undetectable for at least 1 year after that protein converted to negative, before stopping treatment (confirm with trial site).
- People who did not have that specific hepatitis B protein (HBeAg) detected in their blood and whose hepatitis B virus levels have remained undetectable for at least 2 years before stopping treatment (confirm with trial site).
Who may not be able to join:
- People who have liver cirrhosis (scarring of the liver) or liver cancer (HCC).
- People whose liver disease is being caused by something other than hepatitis B.
- People who are currently pregnant or breastfeeding.
- People who have HIV or a condition where the immune system does not work properly from birth.
- People who have severe diabetes, autoimmune diseases, serious problems with other major organs, or other significant health complications.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Liang Peng, Doctor, Third Affiliated Hospital, Sun Yat-Sen University
Phone: +8613760783281
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
relapse
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.